Clinical Trial

A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants

Name: A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants — clinical trial record (NCT06999083)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The aim of this study is to investigate the safety and tolerability of HB0043 in healthy subjects following single-dose.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-23.

Status change: Recruiting → Completed 2026-06-15

Trial Details

NCT Number	NCT06999083
Lead Sponsor	Shanghai Huaota Biopharmaceutical Co., Ltd.
Conditions	Healthy
Enrollment	52 participants
Start Date	2025-06-03
Primary Completion	2026-02-12 (estimated)
Study Completion	2026-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-17